Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry
NCT ID: NCT03718364
Last Updated: 2025-02-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2010-07-01
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation
NCT04784013
Added Value of SVC Isolation in Patients With Pulmonary Vein Reconnection Undergoing Repeat Ablation for Recurrent Paroxysmal AF
NCT04602169
Long-Standing Persistant Atrial Fibrillation-Pulmonary Vein Isolation With or Without Ablation
NCT00820625
Trigger- vs. Substrate-Ablation for Paroxysmal Atrial Fibrillation
NCT00196183
Unexcitability Along the Ablation as an Endpoint for Atrial Fibrillation Ablation
NCT01724437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
catheter-based ablation of atrial fibrillation (pulmonary vein isolation)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Kuehne, MD
Role: PRINCIPAL_INVESTIGATOR
Cardiology/Electrophysiology, University Hospital Basel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiology/Electrophysiology, University Hospital Basel
Basel, , Switzerland
University Hospital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hildegard Tanner, Prof. Dr. med.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Hennings E, Aeschbacher S, Coslovsky M, Paladini RE, Meyre PB, Voellmin G, Blum L, Kastner P, Ziegler A, Conen D, Zuern CS, Krisai P, Badertscher P, Sticherling C, Osswald S, Knecht S, Kuhne M. Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation. Europace. 2023 Jun 2;25(6):euad149. doi: 10.1093/europace/euad149.
Meyre PB, Sticherling C, Spies F, Aeschbacher S, Blum S, Voellmin G, Madaffari A, Conen D, Osswald S, Kuhne M, Knecht S. C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation. BMC Cardiovasc Disord. 2020 Sep 29;20(1):427. doi: 10.1186/s12872-020-01711-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-00226; me18Kuehne2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.